Medimi AB reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 2.07 million compared to SEK 1.07 million a year ago. Revenue was SEK 2.08 million compared to SEK 1.79 million a year ago.

Net loss was SEK 15.41 million compared to SEK 16.36 million a year ago. Basic loss per share from continuing operations was SEK 0.03 compared to SEK 0.06 a year ago. Diluted loss per share from continuing operations was SEK 0.03 compared to SEK 0.06 a year ago.